Insurance Denials and Supply Issues: Challenges in Accessing COVID-19 Vaccines

Americans seeking the new COVID-19 vaccine are encountering insurance issues and facing unexpected bills, despite promises of free coverage. Some individuals have been denied coverage or charged up to $200 due to complications such as pharmacies being out of network, the vaccine not being listed as an approved medical expense, or requiring prior authorization. These problems highlight the transition of COVID-19 vaccines from a public good to a commercial product, exposing the challenges of dealing with insurance companies and a for-profit healthcare system. While federal officials and insurers are working to resolve these issues, Americans are left frustrated and uncertain about accessing the vaccine.